BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28414732)

  • 61. Association of a Chromosomal Rearrangement Event with Mouse Posterior Polymorphous Corneal Dystrophy and Alterations in Csrp2bp, Dzank1, and Ovol2 Gene Expression.
    Shen AL; Moran SA; Glover EA; Drinkwater NR; Swearingen RE; Teixeira LB; Bradfield CA
    PLoS One; 2016; 11(6):e0157577. PubMed ID: 27310661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Status of higher TGF-β1 and TGF-β2 levels in the aqueous humour of patients with diabetes and cataracts.
    Gao C; Lin X; Fan F; Liu X; Wan H; Yuan T; Zhao X; Luo Y
    BMC Ophthalmol; 2022 Apr; 22(1):156. PubMed ID: 35379202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Posterior corneal vesicles are not associated with the genetic variants that cause posterior polymorphous corneal dystrophy.
    Liskova P; Hafford-Tear NJ; Skalicka P; Malinka F; Jedlickova J; Ďuďáková Ľ; Pontikos N; Davidson AE; Tuft S
    Acta Ophthalmol; 2022 Nov; 100(7):e1426-e1430. PubMed ID: 35174971
    [TBL] [Abstract][Full Text] [Related]  

  • 64. c.-61G>A in OVOL2 is a Pathogenic 5' Untranslated Region Variant Causing Posterior Polymorphous Corneal Dystrophy 1.
    Janeschitz-Kriegl L; Kamdar D; Quinodoz M; Kaminska K; Folcher M; György B; Meyer P; Wild A; Escher P; Scholl HPN; Rivolta C; Goldblum D
    Cornea; 2022 Jan; 41(1):89-94. PubMed ID: 34469340
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical observation of posterior polymorphous corneal dystrophy].
    Pang CJ; Jing Y; Li J; Song XH; Wang LY
    Zhonghua Yan Ke Za Zhi; 2011 Jan; 47(1):17-21. PubMed ID: 21418922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis.
    Krachmer JH
    Trans Am Ophthalmol Soc; 1985; 83():413-75. PubMed ID: 3914130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Total protein concentration and T-cell suppression activity of aqueous humour before and after penetrating keratoplasty.
    Mo JS; Maier P; Böhringer D; Reinshagen H; Sundmacher R; Reinhard T
    Eye (Lond); 2012 Jan; 26(1):153-8. PubMed ID: 22094304
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myofibroblast transformation of cat corneal endothelium by transforming growth factor-beta1, -beta2, and -beta3.
    Petroll WM; Jester JV; Bean JJ; Cavanagh HD
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2018-32. PubMed ID: 9761280
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Involvement of P38MAPK in human corneal endothelial cell migration induced by TGF-β(2).
    Joko T; Shiraishi A; Akune Y; Tokumaru S; Kobayashi T; Miyata K; Ohashi Y
    Exp Eye Res; 2013 Mar; 108():23-32. PubMed ID: 23257207
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of penetrating keratoplasty and deep lamellar keratoplasty for macular corneal dystrophy and risk factors of recurrence.
    Cheng J; Qi X; Zhao J; Zhai H; Xie L
    Ophthalmology; 2013 Jan; 120(1):34-9. PubMed ID: 23017278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Posterior polymorphous dystrophy associated with nonkeratoconic steep corneal curvatures.
    Raber IM; Fintelmann R; Chhabra S; Ribeiro MP; Eagle RC; Orlin SE
    Cornea; 2011 Oct; 30(10):1120-4. PubMed ID: 21760500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum.
    Jang MS; Roldan AN; Frausto RF; Aldave AJ
    Vision Res; 2014 Jul; 100():88-92. PubMed ID: 24780443
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical phenotype of posterior polymorphous corneal dystrophy in a family with a novel ZEB1 mutation.
    Nguyen DQ; Hosseini M; Billingsley G; Héon E; Churchill AJ
    Acta Ophthalmol; 2010 Sep; 88(6):695-9. PubMed ID: 19432861
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TGF-beta2 inhibits AKT activation and FGF-2-induced corneal endothelial cell proliferation.
    Lu J; Lu Z; Reinach P; Zhang J; Dai W; Lu L; Xu M
    Exp Cell Res; 2006 Nov; 312(18):3631-40. PubMed ID: 16963022
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential effects of transforming growth factor-beta2 on corneal endothelial cell proliferation-A role of serum factors.
    Chen KH; Hsu WM; Lee SM
    Exp Eye Res; 2002 Jul; 75(1):61-7. PubMed ID: 12123637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Relationship between Axial Length and Levels of TGF-
    Hsiao Y; Cao Y; Yue Y; Zhou J
    Biomed Res Int; 2021; 2021():8863637. PubMed ID: 33728344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CUGC for posterior polymorphous corneal dystrophy (PPCD).
    Davidson AE; Hafford-Tear NJ; Dudakova L; Sadan AN; Pontikos N; Hardcastle AJ; Tuft SJ; Liskova P
    Eur J Hum Genet; 2020 Jan; 28(1):126-131. PubMed ID: 31201376
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aqueous humor endothelin-1 (Et-1), vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2) levels in Mexican glaucomatous patients.
    Iwabe S; Lamas M; Vásquez Pélaez CG; Carrasco FG
    Curr Eye Res; 2010 Apr; 35(4):287-94. PubMed ID: 20373895
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exclusion of pathogenic promoter region variants and identification of novel nonsense mutations in the zinc finger E-box binding homeobox 1 gene in posterior polymorphous corneal dystrophy.
    Bakhtiari P; Frausto RF; Roldan AN; Wang C; Yu F; Aldave AJ
    Mol Vis; 2013; 19():575-80. PubMed ID: 23559851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.